CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to TAK

C1 Esterase Inhibitor Injection

Phase 2
TAKEDA PHARMACEUTICAL CO LTD (TAK)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Mar '27
TAKPhase 2

C1 Esterase Inhibitor Injection Phase 2 Est. Readout

C1 Esterase Inhibitor Injection
Mar 2027~
CT.gov
00%
Competitive Landscape

0 competitors in Subarachnoid Hemorrhage, Aneurysmal

View Full Landscape
Drug Information

Target Indication

Subarachnoid Hemorrhage, Aneurysmal

Clinical Trial

NCT06359782

Last updated: 10/16/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.